Find Docs

BioTech Navigator Investment Newsletter - 05 01 News Color (Page 15)

Wodocs >> Business : Biotechnology and Pharmaceuticals >> BioTech Navigator Investment Newsletter 05 01 News Color Page 15
BioTech Navigator Investment Newsletter - 05 01 News Color
15
BioTech Sage Report, May 2001
Institutional
Ownership
Institutional
Ownership +/-
Comments
72%
-3%
Q1-01 EPS a loss of 9˘ vs. a loss of Q1-00 6˘ EPS. ABGX will continue to form collaborations, buy below $40.
59%
-3%
Q1 EPS 6˘ lowered than expected. AFFX`s 2001 EPS of 21˘. Maintain buy at this price level.
60%
+2%
Q1 EPS. On track with fall 2001 launch of Flumist provided with FDA approved. Buy under $40.
72%
+3%
The NDA for Attenade (ADHD ) is expected to have FDA completed review by Q3-01. Buy below $25.
49%
+2%
CEGE is a long term play.
20%
NC
CIPH to report Q1-01 earnings on May 1.
77%
NC
CORR still on track to be profitable this year, rate as a buy.
22%
-1%
Provenge for prostate cancer on track for 2002 launch. Attractive buy below $10.
12%
+1%
Report 1st qtr earnings on 4-19, GZBX continues to restructure and wait to see improve profitability.
33%
NC
Q1 EPS of a loss of 12˘ vs. 14˘ Q1-00. Long term play.
37%
-1%
Cialis NDA filing in 2001, expected FDA approval 2002. Buy below $50.
55%
+27%
FDA filing mid-2001 for its C225. Reported 4th qtr earnings. Buy on the dips.
78%
NC
BLA filing for inhaled insulin at the end of the year. Rate as buy.
56%
+1%
Abraelix remains on track for submission of FDA approval, buy on the dips.
82%
-4%
Q1-01 EPS loss of 63˘ vs Q1-00 EPS of 76˘. Consensus loss of 98˘. Buy on strength of EPS and revenue.
29%
+2%
NDA filing for pancreatic cancer second half of 2001. SUPG share price has stabilized, buy below $10.
61%
-1%
Lead AIDS drug on track and projected to be launched in 2002, profitable by 2003, buy on the dips.
80%
-1%
Filing of NDA for tenofovir for AIDS by mid-year. Buy on the dips.
58%
-3%
CAMPATH waiting for final FDA approval.
80%
-1%
Buy on the dips.
70%
NC
VRTX to buy ABSC. Continued to make progress on its product pipeline. Buy on the dips.
56%
NC
Aranesp near term approval and continued growth with product pipeline. Still rate as a buy.
49%
NC
1st qtr earnings in line with the Street. BGEN reaffirms 2001 guidance. Still rate as a buy.
31%
-1%
Q1 EPS 19˘. Beat estimates by 2˘ Expected growth will be sure and steady. Buy on dips.
78%
-6%
Q1 quarter of EPS 55
˘
compared to 53
˘
. 2001 Renagel will support growth of 2001 EPS forecast of $2.25 to $2.35. 2: 1 split in 5-01
37%
+1%
FDA hearing on Xolair delayed, Velentri studies to re-envaluated.. Rate as hold.
81%
-2%
2001 Q1 EPS of 12˘ compared to 2000 Q1 of a loss of 3˘. Delayed Zevalin FDA approval. Buy on dips.
40%
-1%
2001 Q1 EPS of 7˘ compared to 2001 Q1 of 6˘.
70%
NC
Continued strong sales and product pipeline. Buy on the dips.
81%
+1%
Stock to split 2:1 in 5-01 and the company outlook remains upbeat. Buy on the dips.
Tools ­ Institutional Ownership, somebody knows something ....
What's the big money doing? Institutional ownership tracks investment by mutual funds, pension plans, banks, insurance companies, and stock brokerages.
Institutional ownership is a handy benchmark of conventional wisdom on Wall Street. Beyond that, things get tricky.

<< Previous       1 .. 8 9 10 11 12 13 14 15 16       Next >>



Other Documents:
3 03 News Color Blank, News 3 98, News 8 97, 01 01 News Color, 1 00 News, 1 04 News Color Blank, Handpainted Catalog F, Oil Lamps Unlimited E Brochure, Order Form Retailb, Order Form specialpricing, jobapplication, SFmenu 2006, jobapplication, reheating, Holiday menu 2005 2, Signe's Holiday Menu, Holiday menu 2005 2, 22 aug 2001, 22 sept 2003, 31 Aug 2002, Eagles 121605, Rose Bowl Fan 2 Fan 120505, Rose Bowl Preferred 111405, C 15 Entry Form pg 2 ( ENG), C 15 Entry Form pg 2 ( FR), C17 entryform, C18 Community serv, Contessa 15 Finalists, Contessa 15 Semi Finalists, contessa 14 finalists, c16 eng entryform, c16 fr entryform, b.loreal.comp, checklist, Beautynet ad info, CIABC MK, Elevate Media Kit, Salon Ad Specs, hair removal options, Amst Menu Guide 07 02, Amst Menu Guide 07 04, Amst Menu Guide 07 05, Amst Menu Guide 07 06, Amst Menu Guide 07 07, Amst Menu Guide 07 08, Amst Menu Guide 07 09, Amst Menu Guide 07 10, Amst Menu Guide 07 11, Amst Menu Guide 07 13, Amst Menu Guide 07 14,


WODocs | |
All rights reserved. wodocs.comİ 2009
WODocs


New Docs

Documents Category:
Arts (Design, Movies, Music, Radio, Television)
Automotive (Cars, Marine, Motorcycle, ATV, Snowmobiles)
Business (Biotechnology and Pharmaceuticals, Chemicals, Construction and Maintenance, Materials, Real Estate, Services)
Electronics (Computers, Motion Control, Power Supply)
Games (Board, Family, Party, Card, Construction, RC Toys)
Health (Animalm, Beauty, Healthcare, Medicine, Pharmacy, Surgery, Weight Loss)
Home (Accessories, Cooking, Decor and Design, Electrical, Family, Pets)
News (Newspapers, Sports, Television)
Recreation (Collecting, Hiking, Scouting, Survival, Travel)
Reference (Education, Libraries and Archives, Museums)
Science (Agriculture, Astronomy, Biology, Chemistry)
Shopping (Antiques and Collectibles, Clothing, Flowers, Food, Home and Garden)
Sports (Bicycle, Snowboard, Skiing, Other)